Range
8.32 - 8.78
Vol / Avg.
669.6K/1.1M
Div / Yield
-
52 Wk
6.7 - 22
Mkt Cap
877M
Payout Ratio
-
Open
8.63
P/E
-
EPS
-0.69
Shares
102M
Outstanding
102M
Total Float
64.6M
Sector: Health Care.Industry: Biotechnology
Epizyme Inc is a clinical-stage biopharmaceutical company that is committed to rewriting treatment for cancer and other serious diseases through discovering, developing and commercializing novel epigenetic medicines. Its product candidates include tazemetostat, an inhibitor of the EZH2, which is in Phase II clinical trial for patients with relapsed or refractory non-hodgkin lymphoma (NHL), Phase II clinical trial for relapsed or refractory patients with mesothelioma, Phase I dose-escalation and expansion study for children with INI1-negative solid tumors. The company is also developing additional programs, such as pinometostat, an intravenously administered small molecule inhibitor of DOT1L for the treatment of acute leukemias and PRMT5 inhibitor.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-03
REV
Q1 2021Est.ActualSurprise
EPS-0.580-0.690 -0.1100
REV6.560M7.631M1.071M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
EPZMEpizyme0%877M

Epizyme Frequently Asked Questions

Q

How do I buy Epizyme (EPZM) stock?

A

You can purchase shares of Epizyme (NASDAQ: EPZM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Epizyme's (EPZM) competitors?

Q

What is the target price for Epizyme (EPZM) stock?

A

The latest price target for Epizyme (NASDAQ: EPZM) was reported by Morgan Stanley on May 7, 2021. The analyst firm set a price target for 10.00 expecting EPZM to rise to within 12 months (a possible 16.28% upside). 8 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Epizyme (EPZM)?

A

The stock price for Epizyme (NASDAQ: EPZM) is $8.6 last updated Today at 8:00:02 PM.

Q

Does Epizyme (EPZM) pay a dividend?

A

There are no upcoming dividends for Epizyme.

Q

When is Epizyme (NASDAQ:EPZM) reporting earnings?

A
Epizyme’s Q2 earnings are confirmed for after-market on August 3, 2021.
Q

Is Epizyme (EPZM) going to split?

A

There is no upcoming split for Epizyme.

Q

What sector and industry does Epizyme (EPZM) operate in?

A

Epizyme is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.